Identification of theranostic biomarkers to improve the stratification of patients with pediatric liver cancer: Opportunities and challenges

Hepatology. 2018 Jul;68(1):10-12. doi: 10.1002/hep.29779. Epub 2018 May 15.

Authors

Carolina Armengol¹, Stefano Cairo²

Affiliations

¹ Childhood Liver Oncology Group (c-LOG)-CIBEREHD, Program for Predictive and Personalized Medicine of Cancer (PMPPC), Germans Trias i Pujol Research Institute (IGTP) I Campus Can Ruti, Badalona, Spain.
² R&D Department, XenTech, Evry, France.

PMID: 29328497
DOI: 10.1002/hep.29779

No abstract available

Publication types

Editorial
Comment

MeSH terms

Biomarkers
Child
Hepatoblastoma*
Humans
Liver Neoplasms
Theranostic Nanomedicine*

Substances

Biomarkers